WHO says hydroxychloroquine coronavirus trials to resume
'On the basis of the available mortality data... the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,' WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.
The World Health Organization on Wednesday said that clinical trials of the drug hydroxychloroquine will resume, having been suspended pending a safety review in the search for coronavirus treatments.
"On the basis of the available mortality data... the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm," WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!